UBS Group’s NCI, Inc. NCIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,361
| Closed | -$29K | – | 8328 |
|
|
2017
Q2 | $29K | Buy |
1,361
+1,136
| +505% | +$19.5K | ﹤0.01% | 6042 |
|
|
2017
Q1 | $3K | Sell |
225
-947
| -81% | -$13.3K | ﹤0.01% | 7249 |
|
|
2016
Q4 | $16K | Buy |
1,172
+1,058
| +928% | +$13.4K | ﹤0.01% | 6665 |
|
|
2016
Q3 | $1K | Sell |
114
-2,001
| -95% | -$25K | ﹤0.01% | 7588 |
|
|
2016
Q2 | $30K | Sell |
2,115
-17,209
| -89% | -$237K | ﹤0.01% | 5950 |
|
|
2016
Q1 | $271K | Buy |
19,324
+18,846
| +3,943% | +$256K | ﹤0.01% | 4277 |
|
|
2015
Q4 | $7K | Buy |
+478
| New | +$7.13K | ﹤0.01% | 7561 |
|
|
2015
Q3 | – | Sell |
-1,781
| Closed | -$18K | – | 8872 |
|
|
2015
Q2 | $18K | Buy |
1,781
+301
| +20% | +$3.16K | ﹤0.01% | 6996 |
|
|
2015
Q1 | $15K | Sell |
1,480
-858
| -37% | -$9.69K | ﹤0.01% | 7311 |
|
|
2014
Q4 | $24K | Buy |
+2,338
| New | +$24.6K | ﹤0.01% | 7415 |
|
UBS Group's NCIT Position: Q3 2017 in Review
UBS Group sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 1,361 shares — an estimated $29K sold.
UBS Group first reported a position in NCIT in Q4 2014 and held it in 10 quarters. The position peaked at $271K in Q1 2016. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.
- UBS Group reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
- UBS Group sold 1,361 NCI, Inc. shares in Q3 2017, an estimated $29K.
- UBS Group first reported a position in NCI, Inc. in Q4 2014 and held it in 10 quarters.
- UBS Group's NCI, Inc. position peaked at $271K in Q1 2016.
- 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.
Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.